Anthony J. Yost
Corporate Officer/Principal at Purdue University
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Sullivan | M | 69 |
Purdue University
| 10 years |
Michael R. Ladisch | M | 74 |
Purdue University
| 25 years |
William E. Baitinger | M | 88 |
Purdue University
| 24 years |
Brian G. Emerick | M | - |
Purdue University
| - |
Allan O. Diefendorf | M | - |
Purdue University
| - |
Jan-Anders Edvin Månsson | M | 72 |
Purdue University
| - |
Andre Hughes | M | - |
Purdue University
| - |
Robert H. Bedoukian | M | - |
Purdue University
| - |
Mark J. T. Smith | M | - |
Purdue University
| - |
Richard O. Buckius | M | - |
Purdue University
| - |
Deborah L. Grubbe | F | - |
Purdue University
| - |
William F. Connors | M | - |
Purdue University
| - |
Mithuna Thottethodi | M | - |
Purdue University
| - |
Mikhail Atallah | M | - |
Purdue University
| 38 years |
George R. Wodicka | M | - |
Purdue University
| - |
David D. Nolte | M | - |
Purdue University
| - |
Fred E. Regnier | M | - |
Purdue University
| - |
Joseph R. Garlich | M | - |
Purdue University
| - |
Don Bergstrom | M | - |
Purdue University
| - |
T. N. Vijaykumar | M | - |
Purdue University
| - |
Steven T. Wereley | M | - |
Purdue University
| 25 years |
Anne Hazlett | F | - |
Purdue University
| - |
Michelle Jansen | F | - |
Purdue University
| - |
Brenda Coulson | F | - |
Purdue University
| - |
David Krull | M | - |
Purdue University
| - |
Candace Shaffer | F | - |
Purdue University
| - |
Teresa Schnarr | F | - |
Purdue University
| - |
William Griffel | M | - |
Purdue University
| - |
Ted McKinney | M | - |
Purdue University
| - |
Andrew Dahlem | M | 64 |
Purdue University
| - |
Gerry McCartney | M | - |
Purdue University
| - |
Jerome Adams | M | 49 |
Purdue University
| 3 years |
Mung Chiang | M | 47 |
Purdue University
| - |
David Sanders | M | - |
Purdue University
| - |
Willie Reed | M | 69 |
Purdue University
| 17 years |
Freddie Barnard | M | - |
Purdue University
| 42 years |
Garnet Peck | M | 93 |
Purdue University
| 57 years |
Maitland Hyslop | M | - |
Purdue University
| - |
David K. Scheele | M | - |
Purdue University
| - |
Norman Blake | M | 82 |
Purdue University
| - |
Gary Lehman | M | 71 |
Purdue University
| 14 years |
Tom H. Scholl | M | - |
Purdue University
| - |
Jon D. Anton | M | - |
Purdue University
| 29 years |
Gerald L. Bepko | M | 83 |
Purdue University
| 21 years |
R. Byron Pipes | M | 82 |
Purdue University
| 20 years |
Vanessa Castagna | F | 73 |
Purdue University
| - |
Jill E. Cook | F | 60 |
Purdue University
| - |
Philip Low | M | 76 |
Purdue University
| 48 years |
Karenann Terrell | F | 62 |
Purdue University
| - |
Shawn Taylor | M | 64 |
Purdue University
| - |
John Timothy McGinley | M | 83 |
Purdue University
| - |
Keith J. Krach | M | 66 |
Purdue University
| - |
Peter Kissinger | M | 79 |
Purdue University
| - |
John J. McConnell | M | 77 |
Purdue University
| 48 years |
Leslie Bottorff | F | - |
Purdue University
| - |
Morgan R. Olsen | M | - |
Purdue University
| - |
Marshall Larsen | M | 75 |
Purdue University
| - |
Patti Penny | F | - |
Purdue University
| 18 years |
Thomas F. Haddock | M | - |
Purdue University
| - |
Manfred R. Koller | M | - |
Purdue University
| - |
Alex D. Oak | M | - |
Purdue University
| - |
Daniel Moore | M | 63 |
Purdue University
| - |
Sangtae Kim | M | - |
Purdue University
| - |
Norman F. Ridder | M | - |
Purdue University
| 18 years |
Nick James | M | - |
Purdue University
| - |
James R. Bottum | M | - |
Purdue University
| - |
Angie Duncan | F | - |
Purdue University
| - |
Thomas V. Easterday | M | - |
Purdue University
| - |
Tim Ogborn | M | - |
Purdue University
| - |
John Landis | M | 71 |
Purdue University
| - |
Daniel F. Evans | M | 74 |
Purdue University
| - |
Joseph B. Hornett | M | - |
Purdue University
| - |
Peggy L. Fish | F | - |
Purdue University
| - |
John Galbraith | M | - |
Purdue University
| 16 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Rick Anderson | M | 63 | 3 years | |
Timothy M. Ruane | M | 59 | - | |
Robert O’Holla | M | 72 | 7 years | |
David Epstein | M | 62 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 6 years |
Usman Azam | M | 55 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | - |
Robert S. Whitehead | M | 74 |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | 1 years |
Evan S. Melrose | M | 54 | 3 years | |
Craig Tooman | M | 58 | 4 years | |
Timothy Patrick Lynch | M | 54 | 3 years | |
Robert P. Roche | M | 68 |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | 1 years |
Tim McInerney | M | 63 | 7 years | |
Joseph M. Mahady | M | 71 |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | 1 years |
Sandra C. Heine | F | 62 | 11 years | |
Brian Levy | M | 72 | 4 years | |
Matthew Luchini | M | - |
Schering-Plough Pharmaceuticals
| 2 years |
Sunil Mehta | M | 65 | - | |
Hao Wu | M | 56 |
Schering-Plough Pharmaceuticals
| 5 years |
Chris Grilliot | M | - |
Schering-Plough Pharmaceuticals
| - |
Neil Ferguson | M | - |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | 8 years |
Rolf Classon | M | 79 |
EKR Therapeutics, Inc.
EKR Therapeutics, Inc. Hospital/Nursing ManagementHealth Services EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products. | - |
C. Lyn Fitzgerald | F | - |
Schering-Plough Pharmaceuticals
| 6 years |
David D. Lilley | M | 66 |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | 21 years |
Andrew Aromando | M | 55 |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | 4 years |
Ricardo Zayas | M | 65 |
Schering-Plough Pharmaceuticals
| 6 years |
Edward F. Heimers | M | 77 |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC. | 5 years |
Heather Hrap | F | 51 |
Schering-Plough Pharmaceuticals
| 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anthony J. Yost
- Personal Network